Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Are Emerging Markets Part Of Big Pharma's Core Business?

This article was originally published in PharmAsia News

Executive Summary

As Big Pharma companies increasingly look to emerging markets to capture some of the growth lost from the patent cliff in the U.S. and Europe, they are also shifting focus more to branded generics, leaving some investors to question whether companies would be better off spinning out their emerging market units, which would leave behind smaller companies focused on the core business of developing and marketing innovative therapies
Advertisement

Related Content

Follow The CEO? Abbott Chief Chooses Diversified Products, Emerging Markets Over Rx Drugs As Company Splits In Two
Pfizer Joins Russia Land Rush, But Chooses To Partner Rather Than Build
Pfizer Joins Russia Land Rush, But Chooses To Partner Rather Than Build
Listing Of MNC Divisions In India Has Been Rough Ride With Stray Sparks Of Hope
Listing Of MNC Arms In India Has Been Rough Ride With Stray Sparks Of Hope
Listing Of MNC Arms In India Has Been Rough Ride With Stray Sparks Of Hope
Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
In R&D Shakeup, Pfizer Tries New Outsourcing Model
Changes Ahead For Pfizer, But Don't Expect A "Big Bang," Read Says
Freed From Pfizer, Capsugel May Find More Market Opportunities
Advertisement
UsernamePublicRestriction

Register

SC078419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel